The Patient Engagement Advantage: Building Stronger Biomedical Brands
We're joined by life sciences strategist Dan Bobear for a discussion about patient-centric commercialization strategies that are transforming the way medical device and biotechnology companies go to market.
Healthcare is at a crossroads. While wellness companies build passionate communities around unproven treatments, evidence-based medicine struggles with trust and engagement. This conversation reveals how forward-thinking companies are bridging that gap—building both clinical excellence and authentic patient relationships. Whether you're launching your first product or leading an established company, this conversation will fundamentally change how you think about patients: Not as end users, but as strategic partners in your success. For more read our comprehensive patient engagement report.
Please feel out the form below and someone from our team will contact you shortly.
Inside the Episode
Strategy
The Patient Engagement Advantage: Building Stronger Biomedical Brands
The Moment of Truth
The Three-Legged Stool
The secret framework behind successful patient partnerships.
Faking It vs. Living It
Patient communities can spot fake empathy from miles away.
The Startup Advantage
The Business Case Revolution
The Trust Equation
Breaking the MLR Barrier
The Health vs. Wellness Divide
A dangerous split is happening in healthcare—and it's getting worse.
The Empathy Engineering Challenge
The Human Connection Imperative
In an age of AI and gene therapy, what remains irreplaceable?
Behind the Scenes
.webp?width=1921&height=1081&name=Content%20Card%20-%20Just%20Mighty%20-%20Boyd%20-%20Two%20Color%20-%20Full%20(1920%20x%201080).webp)
.png?width=401&height=401&name=Logo%20-%20Just%20Mighty%20-%20White%20Logo%20(400%20x%20400).png)